KYNTRA BIO INC
KYNB · NASDAQ
更新于 2026-10-14 09:27:48
$5.87-4.08%
- 今日最高
- $6.21
- 今日最低
- $5.87
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $6.15
- 昨日收盘价
- $6.12
- 成交量
- 2.35万
- 市值
- $2478.06万
- 本益比（P/E）
- 0.13X
- 每股收益（EPS）
- $45.30
昨日价格区间
$6.01$6.34
52周价格区间
$5.62$11.64
公司概况
- 板块
- 医疗保健
- 行业
- 生物技术
- 子行业
- 生物技术
- 总部
- 350 BAY STREET, SAN FRANCISCO, CA, UNITED STATES, 94133
- 国家
- 美国
- 上市日期
- 2014-11-14
- 财年截止
- 十二月
- 流通股数
- 405万
- CIK
- 0000921299
Kyntra Bio, Inc. 是一家生物制药公司，致力于发现、开发和商业化治疗药物，以满足严重未被满足的医疗需求。公司总部位于加利福尼亚州旧金山。
财务指标
营业收入
2026-06-30
-$147.4万
2026-03-31
$373.8万
2025-12-31
$127.7万
2025-09-30
$107.6万
营业支出
2026-06-30
$1609.8万
2026-03-31
$1345万
2025-12-31
$1581.2万
2025-09-30
$631.2万
净利润
2026-06-30
$1197.4万
2026-03-31
-$1519.8万
2025-12-31
$3794.3万
2025-09-30
$1.48亿
净利润率
2026-06-30
-812.34%
2026-03-31
-406.58%
2025-12-31
2.97K%
2025-09-30
13.79K%
每股收益
2026-06-30
$-4.68
2026-03-31
$-3.76
2025-12-31
$-3.51
2025-09-30
$49.61
息税折旧摊销前利润
2026-06-30
-$4948.3万
2026-03-31
-$1269.8万
2025-12-31
-$2095万
2025-09-30
-$1087.1万
有效税率
2026-06-30
0%
2026-03-31
-0.43%
2025-12-31
2.66%
2025-09-30
--
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 营业收入 | -$147.4万 | $373.8万 | $127.7万 | $107.6万 |
| 营业支出 | $1609.8万 | $1345万 | $1581.2万 | $631.2万 |
| 净利润 | $1197.4万 | -$1519.8万 | $3794.3万 | $1.48亿 |
| 净利润率 | -812.34% | -406.58% | 2.97K% | 13.79K% |
| 每股收益 | $-4.68 | $-3.76 | $-3.51 | $49.61 |
| 息税折旧摊销前利润 | -$4948.3万 | -$1269.8万 | -$2095万 | -$1087.1万 |
| 有效税率 | 0% | -0.43% | 2.66% | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。